Skip to main content
. 2018 May 1;9(33):22929–22944. doi: 10.18632/oncotarget.25149

Figure 6. CDDP (cisplatin) treatment reduced the expression of TP53 and FIR in ESCC cells.

Figure 6

(A) Esophageal cancer cell lines (TE2) were exposed to CDDP. The expression of TP53, and FIR was decreased, whereas that of Notch1 was increased. (B) Cyclin E was increased by CDDP treatment (arrows). (C) γH2AX was an indicator of DNA damage as well as T.Tn cells that has pathogenic TP53 mutation (arrows). (D) 5FUtreatment increased cyclin E expression in esophageal cancer cells (TE1 and TE2 cells).